Volume 11, Issue 5 pp. 405-409

Regional citrate anticoagulation in continuous venovenous haemofiltration using commercial preparations

SANDEEP MUNJAL,

SANDEEP MUNJAL

Division of Nephrology, Hypertension and Transplantation, University of Florida, Gainesville, Florida, USA

Search for more papers by this author

A AHSAN EJAZ,

A AHSAN EJAZ

Division of Nephrology, Hypertension and Transplantation, University of Florida, Gainesville, Florida, USA

Search for more papers by this author

SANDEEP MUNJAL,

SANDEEP MUNJAL

Division of Nephrology, Hypertension and Transplantation, University of Florida, Gainesville, Florida, USA

Search for more papers by this author

A AHSAN EJAZ,

A AHSAN EJAZ

Division of Nephrology, Hypertension and Transplantation, University of Florida, Gainesville, Florida, USA

Search for more papers by this author

First published: 29 September 2006

https://doi.org/10.1111/j.1440-1797.2006.00653.x

Citations: 12

Dr A Ahsan Ejaz, Division of Nephrology, Hypertension and Transplantation, University of Florida, PO Box 100224, Gainesville, FL 32610-0224, USA. Email: [email protected]

Share a link

Email
Wechat
Bluesky

SUMMARY:

Aim: The aim of the present study was to test the feasibility of using commercial preparations of replacement and citrate anticoagulation solution in continuous venovenous haemofiltration (CVVH) in a safe, efficient and simple manner.

Methods: Retrospective review of the database of a large continuous renal replacement therapy programme that uses a standardized prescription of high ultrafiltrate CVVH with commercial solutions for replacement fluid and regional citrate anticoagulation was performed.

Results: Records of 28 patients who underwent 91 CVVH sessions were analysed. Median circuit survival time was 37 (59.5–15.5) h and the 48 h survival probability was 40%. Bleeding or metabolic complications were not noted, and the procedure was simple to administer.

Conclusion: Continuous venovenous haemofiltration using commercial preparations of replacement fluid and citrate anticoagulation can be safe, efficient and simple.

REFERENCES

1 Kaplan AA, Longnecker RE, Folkert VW. Continuous arteriovenous hemofiltration. A report of six months' experience. Ann. Intern. Med. 1984; 100: 358–67.
10.7326/0003-4819-100-3-358
CAS PubMed Web of Science® Google Scholar
2 Ward DM, Mehta RL. Extracorporeal management of acute renal failure patients at high risk of bleeding. Kidney Int. 1993; 41: S237–44.
CAS PubMed Google Scholar
3 Paganini EP. Slow continuous hemofiltration and slow continuous ultrafiltration. ASAIO Trans. 1988; 34: 63–6.
PubMed Google Scholar
4 Ponikvar R, Kandus A, Buturovic J, Kveder R. Use of prostacyclin as the only anticoagulant during continuous venovenous hemofiltration. Contrib. Nephrol. 1991; 93: 218–20.
10.1159/000420223
PubMed Web of Science® Google Scholar
5 Ohtake Y, Hirasawa H, Sugai T et al. Nafamostat mesylate as anticoagulant in continuous hemofiltration and continuous hemodiafiltration. Contrib. Nephrol. 1991; 93: 215–17.
10.1159/000420222
PubMed Web of Science® Google Scholar
6 Hory B, Cachoux A, Toulemonde F. Continuous arteriovenous hemofiltration with low-molecular-weight heparin. Nephron 1985; 41: 125.
10.1159/000183563
PubMed Web of Science® Google Scholar
7 Favre H. Hemodialysis, peritoneal dialysis or continuous extracorporeal epuration in acute renal failure patients. Contrib. Nephrol. 1989; 71: 100–103.
CAS PubMed Google Scholar
8 Hofbauer R, Moser D, Frass M et al. Effect of anticoagulation on blood membrane interactions during hemodialysis. Kidney Int. 1999; 56: 1578–83.
10.1046/j.1523-1755.1999.00671.x
CAS PubMed Web of Science® Google Scholar
9 Continault O, Kamar N, Bories P et al. Regional citrate anticoagulation in continuous venovenous haemodiafiltration using commercial solutions. Nephrol. Dial. Transplant. 2004; 19: 171–8.
10.1093/ndt/gfg488
PubMed Web of Science® Google Scholar
10 Kutsogiannis DJ, Mayers I, Chin WDN, Gibney RTN. Regional citrate anticoagulation in continuous venovenous hemodiafiltration. Am. J. Kidney Dis. 2000; 35: 802–11.
10.1016/S0272-6386(00)70248-4
CAS PubMed Web of Science® Google Scholar
11 Lohr JW, Slusher S, Diedrich D. Safety of regional citrate hemodialysis in acute renal failure. Am. J. Kidney Dis. 1989; 13: 104–7.
10.1016/S0272-6386(89)80126-X
PubMed Web of Science® Google Scholar
12 Mehta RL, McDonald BR, Aguilar MM, Ward DM. Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int. 1990; 38: 976–81.
10.1038/ki.1990.300
CAS PubMed Web of Science® Google Scholar
13 Ashton DN, Mehta RL, Ward DM, McDonald BR, Aguilar MM. Recent advances in continuous renal replacement therapy: Citrate anticoagulated continuous arteriovenous hemodialysis. ANNA J. 1991; 18: 263–7.
CAS PubMed Google Scholar
14 Mitchell A, Daul AE, Beiderlinden M et al. A new system for regional citrate anticoagulation in continuous venovenous hemodialysis (CVVHD). Clin. Nephrol. 2003; 59: 106–14.
10.5414/CNP59106
CAS PubMed Web of Science® Google Scholar
15 Palsson R, Niles JL. Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding. Kidney Int. 1999; 55: 1991–7.
10.1046/j.1523-1755.1999.00444.x
CAS PubMed Web of Science® Google Scholar
16 Cointault O, Kamar N, Bories P et al. Regional citrate anticoagulation in continuous venovenous haemodiafiltration using commercial solutions. Nephrol. Dial. Transplant. 2004; 19: 171–8.
10.1093/ndt/gfg488
CAS PubMed Web of Science® Google Scholar
17 Bunchman TE, Maxvold NJ, Brophy PD. Pediatric convective hemofiltration: Normocarb replacement fluid and citrate anticoagulation. Am. J. Kidney Dis. 2003; 42: 1248–52.
10.1053/j.ajkd.2003.08.026
PubMed Web of Science® Google Scholar
18 Meier-Kriesche HU, Finkel KW, Gitomer JJ, DuBose TD Jr. Unexpected severe hypocalcemia during continuous venovenous hemodialysis with regional citrate anticoagulation. Am. J. Kidney Dis. 1999; 33: e8.
10.1016/S0272-6386(99)70249-0
CAS PubMed Google Scholar
19 Monchi M, Berghmans D, Ledoux D, Canivet JL, Dubois B, Damas P. Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: A prospective randomized study. Intensive Care Med. 2004; 30: 260–65.
10.1007/s00134-003-2047-x
PubMed Web of Science® Google Scholar
20 Ronco C, Bellomo R, Homel P et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: A prospective randomised trial. Lancet 2000; 356: 26–30.
10.1016/S0140-6736(00)02430-2
CAS PubMed Web of Science® Google Scholar
21 Tolwani AJ, Campbell RC, Schenk MB, Allon M, Warnock DG. Simplified citrate anticoagulation for continuous renal replacement therapy. Kidney Int. 2001; 60: 370–74.
10.1046/j.1523-1755.2001.00809.x
CAS PubMed Web of Science® Google Scholar
22 Hoffman RM, Maloney C, Ward DM, Becker BN. A novel method for regional citrate anticoagulation in continuous venovenous hemofiltration (CVVHF). Ren. Fail. 2002; 24: 325–35.
10.1081/JDI-120005366
PubMed Web of Science® Google Scholar
23 Gabutti L, Marone C, Colucci G, Duchini F, Schonholzer C. Citrate anticoagulation in continuous venovenous hemodiafiltration: A metabolic challenge. Intensive Care Med. 2002; 28: 1419–25.
10.1007/s00134-002-1443-y
PubMed Web of Science® Google Scholar
24 Tan HK, Baldwin R, Bellomo R. Continuous venovenous hemofiltration without anticoagulation in high-risk patients. Intensive Care Med. 2000; 26: 1652–7.
10.1007/s001340000691
CAS PubMed Web of Science® Google Scholar
25 Uchino S, Fealy N, Baldwin I, Morimatsu H, Bellomo R. Continuous venovenous hemofiltration without anticoagulation. ASAIO J. 2004; 50: 76–80.
10.1097/01.MAT.0000104822.30759.A7
CAS PubMed Web of Science® Google Scholar

Citing Literature

Volume11, Issue5

October 2006

Pages 405-409

Regional citrate anticoagulation in continuous venovenous haemofiltration using commercial preparations

SUMMARY:

REFERENCES

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Regional citrate anticoagulation in continuous venovenous haemofiltration using commercial preparations

SUMMARY:

REFERENCES

Citing Literature

References

Related

Information